| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Frazier Life Sciences Public Fund, L.P. | 8.6% | 0% | $70.4M | 5.99M | 0% | James N. Topper | 01 Nov 2025 | |
| MILLENNIUM MANAGEMENT LLC | 7.1% | +20% | $59.8M | $10.8M | 5.08M | +22.1% | Millennium Management LLC | 30 Sep 2025 |
| Carlyle Group Inc. | 4.9% | $30.1M | 3.5M | Carlyle Group Inc. | 28 Aug 2025 | |||
| BlackRock, Inc. | 4.6% | $14.1M | 3.23M | BlackRock, Inc. | 31 Mar 2025 | |||
| PRUDENTIAL FINANCIAL INC | 0% | -100% | $8.71K | -$24.5M | 2.63K | -100% | PRUDENTIAL FINANCIAL INC | 31 May 2025 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 62.3M | $734M | +$59M | $11.77 | 132 |
| 2025 Q2 | 57.4M | $551M | -$26.7M | $9.59 | 117 |
| 2025 Q1 | 64M | $401M | -$24.9M | $6.27 | 136 |
| 2024 Q4 | 66.6M | $541M | -$121M | $8.12 | 141 |
| 2024 Q3 | 72.6M | $1.31B | +$264M | $18.08 | 133 |
| 2024 Q2 | 58.1M | $599M | +$27.9M | $10.30 | 113 |
| 2024 Q1 | 55.4M | $588M | +$14.6M | $10.62 | 112 |
| 2023 Q4 | 54.1M | $503M | +$11.4M | $9.13 | 115 |
| 2023 Q3 | 43.8M | $453M | +$5.27M | $10.37 | 109 |
| 2023 Q2 | 42.8M | $613M | +$176M | $14.32 | 103 |
| 2023 Q1 | 30.8M | $220M | +$28.3M | $7.14 | 83 |
| 2022 Q4 | 28.2M | $317M | -$21.7M | $11.22 | 83 |
| 2022 Q3 | 30.2M | $334M | +$38M | $11.08 | 87 |
| 2022 Q2 | 27.3M | $230M | +$9.34M | $8.44 | 88 |
| 2022 Q1 | 25.7M | $349M | -$176M | $13.61 | 74 |
| 2021 Q4 | 28.6M | $562M | +$49.9M | $19.67 | 82 |
| 2021 Q3 | 25.5M | $820M | +$19.2M | $32.10 | 81 |
| 2021 Q2 | 24.9M | $844M | +$13.2M | $33.85 | 76 |
| 2021 Q1 | 24.5M | $919M | +$1.76M | $37.56 | 82 |
| 2020 Q4 | 24.5M | $815M | +$96.7M | $33.22 | 75 |
| 2020 Q3 | 21.6M | $794M | -$7.64M | $36.67 | 57 |
| 2020 Q2 | 21.8M | $719M | -$3.03M | $32.91 | 59 |
| 2020 Q1 | 21.9M | $566M | +$3.22M | $25.82 | 47 |
| 2019 Q4 | 21.8M | $677M | +$593M | $31.14 | 40 |